HSBC Holdings’s Novo Nordisk NVO Stock Holding History
Bought
Maintained
Sold
Other funds holding NVO
DAM
F
HSBC Holdings's NVO Position: Q1 2026 in Review
HSBC Holdings increased its Novo Nordisk (NVO) stake by 96% in Q1 2026, buying an estimated $20.9M and bringing the position to 899,804 shares worth $32.7M. The position accounts for 0.02% of the portfolio, ranked #620.
HSBC Holdings first reported a position in NVO in Q3 2014 and has held it in 47 quarters since. The position peaked at $55M in Q2 2023. 1,272 funds tracked by Wall St. Rank hold NVO as of Q1 2026.
- HSBC Holdings held 899,804 shares of Novo Nordisk worth $32.7M as of Q1 2026.
- HSBC Holdings bought 440,571 Novo Nordisk shares in Q1 2026, an estimated $20.9M.
- Novo Nordisk made up 0.02% of HSBC Holdings's portfolio in Q1 2026, its #620 holding.
- HSBC Holdings first reported a position in Novo Nordisk in Q3 2014 and has held it in 47 quarters since.
- HSBC Holdings's Novo Nordisk position peaked at $55M in Q2 2023.
- 1,272 funds tracked by Wall St. Rank held Novo Nordisk as of Q1 2026.
Based on HSBC Holdings's 13F filing for Q1 2026, filed 30 Apr 2026.